Effects of recombinant human growth hormone (rhGH) administration on body composition and cardiovascular risk factors in obese adolescent girls
Conclusions:
Administering rhGH in small doses is able to stabilize IGF-1 levels in obesity. We have also shown that rhGH administration leads to an improvement in some markers of cardiovacular risk with without adversely affecting glucose tolerance.Trial registration: Clinical Trial Registration Number: NCT01169103.
Source: International Journal of Pediatric Endocrinology - Category: Endocrinology Authors: Meghan SlatteryMiriam BredellaTakara StanleyMartin TorrianiMadhusmita Misra Source Type: research
More News: Cardiology | Cardiovascular | Cholesterol | Clinical Trials | Eating Disorders & Weight Management | Endocrinology | Girls | Heart | Hormones | Insulin | Obesity | Pediatrics | Students | Study | Universities & Medical Training